Xiaoshan Zhang Selected Research

Xiaoshan Zhang Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 12/2011
6	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2016
2	Lymphoma (Lymphomas) 01/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2018
2	Aneuploidy (Aneuploid) 01/2021 - 01/2019
2	Carcinogenesis 01/2021 - 06/2015
2	Rheumatoid Arthritis 02/2020 - 01/2016
2	Atherosclerosis 01/2015 - 06/2011
2	Homozygous Familial Hypercholesterolemia 10/2010 - 09/2010
1	Reperfusion Injury 07/2022
1	Fibrosis (Cirrhosis) 07/2022
1	Lupus Nephritis 01/2022
1	Myocardial Infarction 01/2022
1	Thrombosis (Thrombus) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Epstein-Barr Virus Infections 01/2022
1	Dysbiosis 01/2022
1	Hypertension (High Blood Pressure) 03/2021
1	Body Weight (Weight, Body) 03/2021
1	Nephritis 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Prolapse 12/2020
1	Persistent Fetal Circulation Syndrome 07/2020
1	Weight Loss (Weight Reduction) 03/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Leukemia 01/2016
1	Infections 06/2015
1	Heart Failure 01/2015
1	Hyperemia 09/2010

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2015
3	LipidsIBA 07/2022 - 09/2010
3	CytokinesIBA 01/2022 - 06/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 09/2010
2	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2020 - 01/2020
2	Glutathione (Reduced Glutathione)IBA 01/2019 - 01/2019
2	Thioredoxin-Disulfide ReductaseIBA 01/2019 - 01/2019
2	Auranofin (Ridaura)FDA Link 01/2019 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2015
2	LDL CholesterolIBA 10/2010 - 09/2010
1	Oleic Acid (Oleate)IBA 07/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2022
1	rheinIBA 07/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	interleukin-1beta-converting enzyme inhibitorIBA 01/2022
1	belnacasanIBA 01/2022
1	RG7388IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Vancomycin FDA LinkGeneric 03/2021
1	TriazolesIBA 01/2021
1	CYC065IBA 01/2021
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	posaconazole FDA Link 01/2021
1	boron oxide (BO2)IBA 03/2020
1	MicroRNAs (MicroRNA)IBA 02/2020
1	Cystine (L-Cystine)IBA 01/2020
1	DisulfidesIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	navitoclaxIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	trametinibIBA 01/2020
1	Atorvastatin (Lipitor)FDA Link 01/2020
1	EnzymesIBA 01/2019
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2019
1	NAD (NADH)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	ThioredoxinsIBA 01/2019
1	quinone (benzoquinone)IBA 01/2019
1	Glutamate-Cysteine LigaseIBA 01/2019
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 01/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2018
1	Cell-Free Nucleic AcidsIBA 01/2018
1	LigandsIBA 01/2017
1	AntibodiesIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	GoldIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2015
1	oxidized low density lipoproteinIBA 01/2015
1	LDL Receptors (LDL Receptor)IBA 01/2015
1	Ligases (Synthetase)IBA 12/2011
1	ApolipoproteinsIBA 06/2011
1	Apolipoproteins E (ApoE)IBA 06/2011
1	Adenosine (Adenocard)FDA LinkGeneric 09/2010

Therapy/Procedure

5	Therapeutics 01/2022 - 01/2015
2	Aftercare (After-Treatment) 01/2021 - 01/2020
2	Immunotherapy 01/2019 - 01/2017
1	Intraperitoneal Injections 01/2022
1	Catheters 12/2020
1	Radiotherapy 01/2019
1	Cardiac Resynchronization Therapy 01/2015